Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 8Unknown 4Withdrawn 2Terminated 2Recruiting 2Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Stomach Neoplasms 19Esophageal Squamous Cell Carcinoma 3Recurrence 2Pancreatic Neoplasms 2Nasopharyngeal Carcinoma 2Esophageal Neoplasms 2Pancreatic cancer, adult 1Pancreatic Adenocarcinoma 1Pan-tumor 1Neuroendocrine Tumors 1Neoplasms 1Neoplasm Metastasis 1Locally Advanced Gastric or Gastroesophageal Junction Cancer 1Locally Advanced Gastric Adenocarcinoma 1Immunotherapy Gastrict Cancer 1Cholangiocarcinoma 1Chemotherapy Effect 1

Interventions

pembrolizumab 16Radiotherapy 15Drug Therapy 14Paclitaxel 13Cisplatin 12Carboplatin 10Immunotherapy 9Esophagectomy 9Radiation 8Fluorouracil 8Surgical Procedures, Operative 7Capecitabine 7Blood Specimen Collection 7Oxaliplatin 6Nivolumab 6Immune Checkpoint Inhibitors 6Chemoradiotherapy 6nimotuzumab 5Trastuzumab 5130-nm albumin-bound paclitaxel 5sintilimab 4camrelizumab 4Leucovorin 4trastuzumab deruxtecan 3tislelizumab 3patritumab deruxtecan 3Surveys and Questionnaires 3Endoscopy 3Bevacizumab 3toripalimab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Esophageal Neoplasms × S 1 (combination) × Clear all
NCT07038629 2026-05-20

Chemoradiation Plus Iparomlimab Consolidation in Older With ESCC

Tianjin Medical University Cancer Institute and Hospital

Phase 2 Recruiting
52 enrolled
Gastrointestinal

Esophageal Neoplasms

NCT06061146 2023-12-26

TCRTOE

Tianjin Medical University Cancer Institute and Hospital

Phase 2 Recruiting
136 enrolled
Gastrointestinal

Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡